EW

EDWARDS LIFESCIENCES CORP

EW·28176E108·US·Common Stock·Healthcare - Medical Devices-13D/G

EW (EDWARDS LIFESCIENCES CORP) is held by 323 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($5.3B), VANGUARD CAPITAL MANAGEMENT LLC ($3.4B), VANGUARD PORTFOLIO MANAGEMENT LLC ($2.4B). Net institutional sentiment: Mixed. In Q2 2026, 5 members of Congress and 155 funds bought EW.

323
Holders
(29 Elite)
$43.7B
Total Value
47% (331)
Consensus
155 buying - 176 selling
13F: Insider & Congress: Updated regularly
EW

Smart Money Verdict

View all
Loading verdict
Held by 323 funds
29 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Oct 8, 2026 · Activists Apr 29, 2026 · Congress Jul 21, 2026

InsiderLJLippis Daniel J.Sell $53KOct 8, 2026
InsiderLJLippis Daniel J.Exercise 619 shOct 8, 2026
InsiderMWMarkowitz WayneTax 568 shSep 14, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
58.8M(+11.8%)$5.3B0.1%+28.04%
36
Decreased
37.6M(-0.3%)$3.4B0.1%+10.01%
0
Increased
26.4M(+0.0%)$2.4B0.1%+10.01%
38
Increased
26.3M(+0.1%)$2.4B0.1%+16.27%
32
Increased
22.8M(+4.8%)$2.1B0.1%+20.43%
40
Decreased
16.8M(-23.6%)$1.5B0.3%+23.76%
0
Increased
15.4M(+17.5%)$1.4B0.1%+23.51%
37
Decreased
14.1M(-15.8%)$1.3B0.2%+14.30%
0
Increased
13M(+1.5%)$1.2B0.9%+13.60%
46
Decreased
12.3M(-0.5%)$1.1B2.5%+24.56%
0
New
8.7M$783.9M1.6%-2.61%
72
Decreased
8.4M(-41.8%)$763.1M0.0%+11.86%
0
Increased
8.7M(+149.8%)$693.5M0.2%+1.98%
61
Increased
7.4M(+4.8%)$666.3M1.0%+21.63%
52
Increased
6.7M(+72.3%)$605.4M0.0%+5.00%
47
Increased
6.6M(+27.4%)$599.4M1.0%+5.86%
55
Decreased
6.3M(-10.2%)$573.5M0.0%+0.39%
0
Decreased
5.7M(-5.7%)$516.6M0.1%+22.51%
0
Increased
5.7M(+200.3%)$513.6M0.2%+1.24%
61
Decreased
5.7M(-2.6%)$513M0.1%+32.66%
0

Showing 1-20 of 338

1 / 17
EWEWEDWARDS LIFESCIENCES CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used